calendar
1,740 catalysts · 3,603 8k filing · 2,280 grant · 1,740 approval · 1,112 device 510k · 1,000 device adverse event · 815 device pma
1,740 catalysts · 3,603 8k filing · 2,280 grant · 1,740 approval · 1,112 device 510k · 1,000 device adverse event · 815 device pma
no tagged catalysts yet
Sponsor: ANI PHARMS. Form: SOLUTION. Route: ORAL
Sponsor: ANI PHARMS. Form: SOLUTION. Route: ORAL
Sponsor: ANI PHARMS. Form: SOLUTION. Route: ORAL
Sponsor: ANI PHARMS. Form: SOLUTION. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL
Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL
Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL
Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL
Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL
Sponsor: BEIGENE. Form: INJECTION. Route: SOLUTION
Sponsor: BEIGENE. Form: INJECTION. Route: SOLUTION
Sponsor: BEIGENE. Form: INJECTION. Route: SOLUTION
Sponsor: UCB INC. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: GLAXOSMITHKLINE. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: MSD MERCK CO. Form: POWDER. Route: INTRAVENOUS
Sponsor: SHORLA. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: SHORLA. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: GLAXOSMITHKLINE. Form: SPRAY. Route: NASAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: MACLEODS PHARMS LTD. Form: CAPSULE. Route: ORAL
Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION
Sponsor: IMMUNEX. Form: SYRINGE
Sponsor: GENENTECH. Form: INJECTABLE. Route: INJECTION
Sponsor: FOUGERA PHARMS. Form: OINTMENT. Route: TOPICAL
Sponsor: GENENTECH. Form: INJECTABLE. Route: INTRAVENOUS, SUBCUTANEOUS
Sponsor: MUNDIPHARMA. Form: POWDER. Route: INTRAVENOUS
Sponsor: DEVA HOLDING AS. Form: INJECTABLE. Route: INJECTION
Sponsor: SPECGX LLC. Form: TABLET. Route: SUBLINGUAL
Sponsor: ALEMBIC. Form: SUSPENSION/DROPS. Route: OPHTHALMIC
Sponsor: CURIUM. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVITIUM PHARMA. Form: FOR SUSPENSION. Route: ORAL
Sponsor: ACTAVIS LABS FL INC. Form: TABLET. Route: ORAL
Sponsor: TEVA. Form: TABLET. Route: ORAL
Sponsor: LNK INTL INC. Form: TABLET. Route: ORAL
Sponsor: SENORES PHARMS. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: INGENUS PHARMS LLC. Form: TABLET. Route: ORAL
Sponsor: BROOKS STERISCIENCE. Form: INJECTABLE. Route: INJECTION
Sponsor: ASTELLAS. Form: TABLET. Route: ORAL
Sponsor: ASTELLAS. Form: CAPSULE. Route: ORAL
Sponsor: BIOCRYST. Form: PELLETS. Route: ORAL
Sponsor: MSN. Form: INJECTABLE. Route: INJECTION
Sponsor: VIELA BIO. Form: INJECTABLE. Route: INJECTION
Sponsor: ACADIA PHARMS INC. Form: FOR SOLUTION. Route: ORAL